Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

AGL anticorps (C-Term)

AGL Reactivité: Humain WB, IF Hôte: Lapin Polyclonal RB4978 unconjugated
N° du produit ABIN389030
  • Antigène Voir toutes AGL Anticorps
    AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
    Épitope
    • 7
    • 7
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 1479-1510, C-Term
    Reactivité
    • 33
    • 1
    Humain
    Hôte
    • 31
    • 2
    Lapin
    Clonalité
    • 33
    Polyclonal
    Conjugué
    • 14
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp AGL est non-conjugé
    Application
    • 18
    • 18
    • 16
    • 10
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogène
    This AGL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1479-1510 amino acids from the C-terminal region of human AGL.
    Clone
    RB4978
    Isotype
    Ig Fraction
  • Indications d'application
    IF: 1:10~50. IF: 1:10~50. WB: 1:1000. WB: 1:8000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Guin, Ru, Agarwal, Ritterson Lew, Owens, Comi, Theodorescu: "Loss of glycogen debranching enzyme AGL drives bladder tumor growth via induction of hyaluronic acid synthesis." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, (2015) (PubMed).

    Liu, Zeng, Ma, Baba, Zheng, Liu, Wang: "Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase." dans: Molecular neurobiology, Vol. 49, Issue 2, pp. 645-57, (2014) (PubMed).

    Zhu, Shen, Zhu, Coorey, Nguyen, Barthelmes, Gillies: "Anti-retinal antibodies in patients with macular telangiectasia type 2." dans: Investigative ophthalmology & visual science, Vol. 54, Issue 8, pp. 5675-83, (2013) (PubMed).

    DePaoli-Roach, Tagliabracci, Segvich, Meyer, Irimia, Roach: "Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin." dans: The Journal of biological chemistry, Vol. 285, Issue 33, pp. 25372-81, (2010) (PubMed).

    Parker, Kong, Walsh, Salajegheh, Moghadaszadeh, Amato, Nazareno, Lin, Krastins, Sarracino, Beggs, Pinkus, Greenberg: "Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis." dans: Muscle & nerve, Vol. 39, Issue 6, pp. 739-53, (2009) (PubMed).

    Cheng, Zhang, Gentry, Worby, Dixon, Saltiel: "A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease." dans: Genes & development, Vol. 21, Issue 19, pp. 2399-409, (2007) (PubMed).

  • Antigène
    AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
    Autre désignation
    AGL (AGL Produits)
    Synonymes
    anticorps DDBDRAFT_0219237, anticorps DDBDRAFT_0234114, anticorps DDB_0219237, anticorps DDB_0234114, anticorps GDE, anticorps 1110061O17Rik, anticorps 9430004C13Rik, anticorps 9630046L06Rik, anticorps AI850929, anticorps C77197, anticorps amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase, anticorps glycogen debranching enzyme, anticorps glycogen debranching protein, anticorps amylo-1,6-glucosidase, 4-alpha-glucanotransferase, anticorps AGL, anticorps agl, anticorps MMAH_RS03870, anticorps Agl
    Sujet
    AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing.
    Poids moléculaire
    174764
    ID gène
    178
    NCBI Accession
    NP_000019, NP_000633, NP_000634, NP_000635, NP_000636, NP_000637
    UniProt
    P35573
    Pathways
    Cellular Glucan Metabolic Process
Vous êtes ici:
Support technique